Archive |
Impact Of Nanotechnology On Life Sciences
Jan 2010
The Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK’s primary knowledge-based networks for Micro and Nanotechnologies, will again be convening the Nano4Life Conference. Nano4Life 2010, organised by the NanoKTN in collaboration with The Wellcome Trust, will explore the key areas within the life sciences where nanotechnology offers the opportunity to advance healthcare and improve product discovery and development.
The area of bio-nanotechnology is developing rapidly and there is no doubt that it will enhance our understanding of biology and how biological systems work. Nanotechnology is already being used to help resolve some of the pharma and biotech industries' significant problems and this one-day conference and exhibition, taking place in London on February 4th, will look at the ways nanotechnology in healthcare can ensure the UK is kept a leading force in this exciting area of technology.
Last year’s event saw the attendance of 150 industry and academic professionals discuss a number of key issues such as improvements in drug discovery processes, through miniaturisation, automation, speed and reliability.
The keynote presentation at the 2010 event will be delivered by Sir William Castell, Chairman of the Board of Governors at The Wellcome Trust and Board Director of both GE and BP. Other presentations come from Pharmidex Pharmaceutical Services Ltd, NIHR Office for Clinical Research Infrastructure (NOCRI), The Royal Institution and QantuMDx.
“Nanotechnology holds the promise to provide a significant number of healthcare advances and by hosting the Nano4Life conference, we aim to explore the ways in which the technology can be developed and adopted,” explains Dr Mike Fisher, Theme Manager at the NanoKTN.
Fisher continues, “Nano4Life aims to showcase the latest developments in nanotechnology to the science community and provides an environment to catalyse new collaborations. By hosting Nano4Life, the NanoKTN aims to bring together clinicians, academic scientists and industry professionals to drive forward the development of these advances.”
Nano4Life is be organised in partnership with The Wellcome Trust, the largest charity in the UK which spends over £600 million each year to support and promote research to improve the health of humans and animals.
The Trust funds research into all aspects of biology and medicine: from molecules and cells vital to life, through the spread of diseases or the vectors of disease across the globe, to clinical and public health research that can improve the quality of healthcare delivered to people. The Trust is interested in the development of hypothesis driven research which realises an unmet need in biomedical sciences and healthcare. The conference is an opportunity to showcase nanotechnology to the basic science community and provides an environment to catalyse new collaborations.
All sectors of the supply chain are encouraged to register for the Nano4Life conference including research-based pharma, biotech and medical device companies, academics, research policy makers and anyone who is interested in learning about what nanotechnology has to offer the life sciences. For more information please visit www.nano4life.com.
There are a number of exhibition opportunities still available and any interested companies should contact: natasha.taylor@nanoktn.com
Established by the Technology Strategy Board, the NanoKTN is managed by Centre for Process Innovation Ltd, a leading technology development and consulting company.
